FW: [HepC] September HCV Advocate Posted

[Guest guest]

-----Original Message-----From: Demastus@... [mailto:Demastus@...]Sent: Monday, September 11, 2000 9:51 AMHepCegroupsSubject: [HepC] September HCV Advocate Posted

In a message dated 09/11/2000 11:49:33 AM Central Daylight Time, sfhepcat@... writes:September 2000's Advocate - <A HREF="http://www.hcvadvocate.org/">www.hcvadvocate.org</A>:FDA Advisory Panel Recommends Approval of Hoffmann-LaRoche's Viral Load Test - If approved, this would be the first FDA-approved HCV viral load test. Healthwise: African Americans and Hepatitis C - Differences in Treatment Response, Cirrhosis Rates Need More Study. Liver Cells in Bone Marrow: Exciting New Research for Future Therapies - Study may help to explain how liver cells regenerate.Hoffman-LaRoche and Maxim Combine Forces for New HCV Combination Therapy -Pegasys, a pegylated interferon is being tested for use with Maximine, a drug believed to reverse immune suppresion.Treatment Advocate: A Little About the HCV Global Conference, Some Incredible People and a Little Chinese Medicine -While pricey, the English version of the Chinese Pharmacopoeia is the bible of Chinese medicine. The Rules Have Changed...Get Paid to Surf the Web! <A HREF="http://www.alladvantage.com/home.asp?refid=FVG-196">http://www.alladvantage.com/go.asp?refid=FVG-196</A>

[Guest guest]

-----Original Message-----From: Demastus@... [mailto:Demastus@...]Sent: Monday, September 11, 2000 9:51 AMHepCegroupsSubject: [HepC] September HCV Advocate Posted

In a message dated 09/11/2000 11:49:33 AM Central Daylight Time, sfhepcat@... writes:September 2000's Advocate - <A HREF="http://www.hcvadvocate.org/">www.hcvadvocate.org</A>:FDA Advisory Panel Recommends Approval of Hoffmann-LaRoche's Viral Load Test - If approved, this would be the first FDA-approved HCV viral load test. Healthwise: African Americans and Hepatitis C - Differences in Treatment Response, Cirrhosis Rates Need More Study. Liver Cells in Bone Marrow: Exciting New Research for Future Therapies - Study may help to explain how liver cells regenerate.Hoffman-LaRoche and Maxim Combine Forces for New HCV Combination Therapy -Pegasys, a pegylated interferon is being tested for use with Maximine, a drug believed to reverse immune suppresion.Treatment Advocate: A Little About the HCV Global Conference, Some Incredible People and a Little Chinese Medicine -While pricey, the English version of the Chinese Pharmacopoeia is the bible of Chinese medicine. The Rules Have Changed...Get Paid to Surf the Web! <A HREF="http://www.alladvantage.com/home.asp?refid=FVG-196">http://www.alladvantage.com/go.asp?refid=FVG-196</A>

[Guest guest]

-----Original Message-----From: Demastus@... [mailto:Demastus@...]Sent: Monday, September 11, 2000 9:51 AMHepCegroupsSubject: [HepC] September HCV Advocate Posted

In a message dated 09/11/2000 11:49:33 AM Central Daylight Time, sfhepcat@... writes:September 2000's Advocate - <A HREF="http://www.hcvadvocate.org/">www.hcvadvocate.org</A>:FDA Advisory Panel Recommends Approval of Hoffmann-LaRoche's Viral Load Test - If approved, this would be the first FDA-approved HCV viral load test. Healthwise: African Americans and Hepatitis C - Differences in Treatment Response, Cirrhosis Rates Need More Study. Liver Cells in Bone Marrow: Exciting New Research for Future Therapies - Study may help to explain how liver cells regenerate.Hoffman-LaRoche and Maxim Combine Forces for New HCV Combination Therapy -Pegasys, a pegylated interferon is being tested for use with Maximine, a drug believed to reverse immune suppresion.Treatment Advocate: A Little About the HCV Global Conference, Some Incredible People and a Little Chinese Medicine -While pricey, the English version of the Chinese Pharmacopoeia is the bible of Chinese medicine. The Rules Have Changed...Get Paid to Surf the Web! <A HREF="http://www.alladvantage.com/home.asp?refid=FVG-196">http://www.alladvantage.com/go.asp?refid=FVG-196</A>

[Guest guest]

-----Original Message-----From: Demastus@... [mailto:Demastus@...]Sent: Monday, September 11, 2000 9:51 AMHepCegroupsSubject: [HepC] September HCV Advocate Posted

In a message dated 09/11/2000 11:49:33 AM Central Daylight Time, sfhepcat@... writes:September 2000's Advocate - <A HREF="http://www.hcvadvocate.org/">www.hcvadvocate.org</A>:FDA Advisory Panel Recommends Approval of Hoffmann-LaRoche's Viral Load Test - If approved, this would be the first FDA-approved HCV viral load test. Healthwise: African Americans and Hepatitis C - Differences in Treatment Response, Cirrhosis Rates Need More Study. Liver Cells in Bone Marrow: Exciting New Research for Future Therapies - Study may help to explain how liver cells regenerate.Hoffman-LaRoche and Maxim Combine Forces for New HCV Combination Therapy -Pegasys, a pegylated interferon is being tested for use with Maximine, a drug believed to reverse immune suppresion.Treatment Advocate: A Little About the HCV Global Conference, Some Incredible People and a Little Chinese Medicine -While pricey, the English version of the Chinese Pharmacopoeia is the bible of Chinese medicine. The Rules Have Changed...Get Paid to Surf the Web! <A HREF="http://www.alladvantage.com/home.asp?refid=FVG-196">http://www.alladvantage.com/go.asp?refid=FVG-196</A>